{"id":938674,"date":"2026-02-20T08:35:50","date_gmt":"2026-02-20T13:35:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/"},"modified":"2026-02-20T08:35:50","modified_gmt":"2026-02-20T13:35:50","slug":"nasus-pharma-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Nasus Pharma to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>TEL AVIV, Feb.  20, 2026  (GLOBE NEWSWIRE) &#8212; Nasus Pharma Ltd. (NYSE: NSRX) (&#8220;Nasus Pharma&#8221; or the &#8220;Company&#8221;), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March.<\/p>\n<p>\n        <b>Oppenheimer 36th Annual Healthcare Life Sciences Conference<\/b>\n      <\/p>\n<ul>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Date and time: February 25, 2026, 1:20 p.m. ET<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Location: Virtual (<a href=\"https:\/\/event.summitcast.com\/view\/CTtthLh2Bi2D9aYoKpvtEv\/KoYPJS8x3zqMuXPHfEHoSY\" rel=\"nofollow\" target=\"_blank\">register here:<\/a><a href=\"https:\/\/event.summitcast.com\/view\/CTtthLh2Bi2D9aYoKpvtEv\/KoYPJS8x3zqMuXPHfEHoSY\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.summitcast.com\/view\/CTtthLh2Bi2D9aYoKpvtEv\/KoYPJS8x3zqMuXPHfEHoSY<\/a>)<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Format: Company presentation<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Speaker: Dan Teleman, Chief Executive Officer<\/li>\n<\/ul>\n<p>\n        <b>BIO Investment &amp; Growth Summit <\/b>\n      <\/p>\n<ul>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Date and time: March 2, 2026, 10:15 a.m. ET<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Location: Miami, FL<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Format: Company presentation<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Speaker: Dan Teleman, Chief Executive Officer<\/li>\n<\/ul>\n<p>\n        <b>Citizens Life Sciences Conference<\/b>\n      <\/p>\n<ul>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Date and time: March 11, 2026, 3:25 p.m. ET<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Location: Miami, FL<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Format: Company presentation<\/li>\n<li style=\"margin-top:0cm;margin-bottom:0cm\">Speaker: Dan Teleman, Chief Executive Officer<\/li>\n<\/ul>\n<p>Nasus management will be available for one-on-one meetings during the conferences. Interested parties should contact their conference representative to arrange a meeting.<\/p>\n<p>\n        <b>About Nasus Pharma<br \/><\/b>Nasus Pharma is a clinical-stage pharmaceutical company developing a number of intranasal powder products\u00a0addressing acute medical conditions in the community. NS002, Nasus\u2019 intranasal powder Epinephrine product candidate is being developed as a needle-free alternative to Epinephrine autoinjectors for patients with anaphylaxis.\u00a0Intranasal administration is most suitable for those situations in which rapid drug delivery is required and offers\u00a0needle-free, easy-to-use alternatives. Nasus\u2019 proprietary powder-based intranasal (\u201cPBI\u201d) technology is designed for rapid and reliable drug delivery, leveraging the nasal cavity\u2019s rich vascular network for quick absorption. The PBI formulation uses uniform spherical powder particles for broad dispersion and potentially faster, higher absorption compared to liquid-based nasal products. For further information about the Company, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V0D08s96mMB40KpGlXg_wHhYUQ3ujIWvq8AQnjmihPRg69akqTQpKvMjzuQefq07cqZc6s11F-_bbC62Dy_p7PJHgb_tSIWMSdmbLEhAq3DgCz_-0PNYL1fB6bMUM0lfMzzKl3WO_ByZUsXWMAeWzx5ErHkGCaj5nUWKq5l4RLn5oq66Za3nBLCfK3o1gVY0q-Ranrc-oU3BJ2rOXMjWRhoBhCx1WHqRvA9wqAp6GH_wAwc64m2RY3wqyj-zIOLh5nwvMcH6ADTqU_H0ITf7aMSes7hVkW3k0I4WM1hxR-_mZ1kifn0WIMjpFerxgtTTrzSLw7J_f--Z3NktgR3w4ot4rnZyvjt4nmKB7LjIM-Uk7SOiVfxmZ9Bh1bydaoOIXrO1XJehe2nU6MY1YQnaKpz81OkwseQ1GcSKS5QaZF9A5Fx1KFzBn5edysoxVwXkta7RQS1GoU3n2U7Q-wR1HyYEVjNKnXJ7CX9GRQGyEjjJZe9G-x73ZeaNMi0NII1Z\" rel=\"nofollow\" target=\"_blank\">www.nasuspharma.com<\/a>\u00a0or follow on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5ruc9UV3ZO1d5tcY_yFVS81GcN4nSGc8QoEyVTockYqXzL_JCfoM4vUWkty-g1e56CppOtDkEv3sXCBLhYU8WrKQH0PdI8WUXpJjQ8ZCAms=\" rel=\"nofollow\" target=\"_blank\">Twitter (X)<\/a>\u00a0or\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=avKpUvkz8p1NMkAEEYSWcyTH4F4bOdYA8fScTOhMupfvpOPstRs_PZOS5LesIGJUQf_GS1D7eY6EmpUpDYxSmGPX1vU57bHeivogpeLlkHuDQFKQqx_x2ttYqZWpbkii\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <b>Company Contact<br \/><\/b>Nasus Pharma Ltd.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FB74yJfCoSk4SCTVyXLyRAXbgwwlBawpF92SXk-iUniB9BZK5dDG4Xftti4Zj1-6HU4xMhxYehdzDLNnjxNSbt6-CRrpim_b-FpHNU0Gsyc=\" rel=\"nofollow\" target=\"_blank\">info@nasuspharma.com<\/a><\/p>\n<p>\n        <b>Investor Contact<br \/><\/b>Mike Moyer<br \/>LifeSci Advisors<br \/>+1-617-308-4306<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_qt6D8XvIG-8kJkrJRbow2DragojtUljj2p7YcDuoWipqykuXW2JiJY8s7eB8aZ9j88OaztxjdZL9LIamYmjO0VlMOy26rW8DIKkGU1wbidp3SstE7I7dXZE1fi59Y8f\" rel=\"nofollow\" target=\"_blank\">mmoyer@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NzU2Mjk0YmMtM2QyMi00ZTViLWJlOTYtZTQ5MDkwYjZhZDc3LTcwMDAyNjQxNS0yMDI2LTAyLTIwLWVu\/tiny\/Nasus-Pharma-Ltd-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) &#8212; Nasus Pharma Ltd. (NYSE: NSRX) (&#8220;Nasus Pharma&#8221; or the &#8220;Company&#8221;), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March. Oppenheimer 36th Annual Healthcare Life Sciences Conference Date and time: February 25, 2026, 1:20 p.m. ET Location: Virtual (register here:https:\/\/event.summitcast.com\/view\/CTtthLh2Bi2D9aYoKpvtEv\/KoYPJS8x3zqMuXPHfEHoSY) Format: Company presentation Speaker: Dan Teleman, Chief Executive Officer BIO Investment &amp; Growth Summit Date and time: March 2, 2026, 10:15 a.m. ET Location: Miami, FL Format: Company presentation Speaker: Dan Teleman, Chief Executive Officer Citizens Life Sciences Conference Date and time: March 11, 2026, 3:25 p.m. ET Location: Miami, FL Format: Company presentation Speaker: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nasus Pharma to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-938674","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nasus Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nasus Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) &#8212; Nasus Pharma Ltd. (NYSE: NSRX) (&#8220;Nasus Pharma&#8221; or the &#8220;Company&#8221;), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March. Oppenheimer 36th Annual Healthcare Life Sciences Conference Date and time: February 25, 2026, 1:20 p.m. ET Location: Virtual (register here:https:\/\/event.summitcast.com\/view\/CTtthLh2Bi2D9aYoKpvtEv\/KoYPJS8x3zqMuXPHfEHoSY) Format: Company presentation Speaker: Dan Teleman, Chief Executive Officer BIO Investment &amp; Growth Summit Date and time: March 2, 2026, 10:15 a.m. ET Location: Miami, FL Format: Company presentation Speaker: Dan Teleman, Chief Executive Officer Citizens Life Sciences Conference Date and time: March 11, 2026, 3:25 p.m. ET Location: Miami, FL Format: Company presentation Speaker: &hellip; Continue reading &quot;Nasus Pharma to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-20T13:35:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nasus Pharma to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-02-20T13:35:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":307,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Nasus Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1\",\"datePublished\":\"2026-02-20T13:35:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasus-pharma-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nasus Pharma to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nasus Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Nasus Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) &#8212; Nasus Pharma Ltd. (NYSE: NSRX) (&#8220;Nasus Pharma&#8221; or the &#8220;Company&#8221;), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March. Oppenheimer 36th Annual Healthcare Life Sciences Conference Date and time: February 25, 2026, 1:20 p.m. ET Location: Virtual (register here:https:\/\/event.summitcast.com\/view\/CTtthLh2Bi2D9aYoKpvtEv\/KoYPJS8x3zqMuXPHfEHoSY) Format: Company presentation Speaker: Dan Teleman, Chief Executive Officer BIO Investment &amp; Growth Summit Date and time: March 2, 2026, 10:15 a.m. ET Location: Miami, FL Format: Company presentation Speaker: Dan Teleman, Chief Executive Officer Citizens Life Sciences Conference Date and time: March 11, 2026, 3:25 p.m. ET Location: Miami, FL Format: Company presentation Speaker: &hellip; Continue reading \"Nasus Pharma to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-20T13:35:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nasus Pharma to Participate in Upcoming Investor Conferences","datePublished":"2026-02-20T13:35:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/"},"wordCount":307,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/","name":"Nasus Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1","datePublished":"2026-02-20T13:35:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE2NTU4NyM0MDIzMzUyMDMjNzAwMDI2NDE1"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasus-pharma-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nasus Pharma to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=938674"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938674\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=938674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=938674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=938674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}